HomeINM • NASDAQ
add
InMed Pharmaceuticals Inc
Previous close
$0.86
Day range
$0.85 - $0.89
Year range
$0.85 - $7.98
Market cap
2.48M USD
Avg Volume
69.46K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 820.19K | -26.22% |
Operating expense | 2.30M | -13.58% |
Net income | -2.03M | 21.23% |
Net profit margin | -247.29 | -6.76% |
Earnings per share | — | — |
EBITDA | -2.07M | 3.97% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.00M | 102.23% |
Total assets | 11.19M | 31.63% |
Total liabilities | 1.60M | -30.88% |
Total equity | 9.59M | — |
Shares outstanding | 2.92M | — |
Price to book | 0.25 | — |
Return on assets | -43.19% | — |
Return on capital | -47.44% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -2.03M | 21.23% |
Cash from operations | -2.38M | 5.03% |
Cash from investing | 0.00 | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -2.38M | -9.83% |
Free cash flow | -1.57M | -8.50% |
About
Founded
1981
Headquarters
Website
Employees
13
